6-129464406-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_000426.4(LAMA2):c.7109C>T(p.Thr2370Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000806 in 1,612,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000426.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital merosin-deficient muscular dystrophy 1AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- LAMA2-related muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy, limb-girdle, autosomal recessive 23Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LAMA2 | ENST00000421865.3 | c.7109C>T | p.Thr2370Ile | missense_variant | Exon 50 of 65 | 5 | NM_000426.4 | ENSP00000400365.2 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151924Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000478 AC: 12AN: 250816 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000835 AC: 122AN: 1460354Hom.: 0 Cov.: 32 AF XY: 0.0000729 AC XY: 53AN XY: 726526 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151924Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74204 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.7109C>T (p.T2370I) alteration is located in exon 50 (coding exon 50) of the LAMA2 gene. This alteration results from a C to T substitution at nucleotide position 7109, causing the threonine (T) at amino acid position 2370 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
LAMA2-related muscular dystrophy Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 2370 of the LAMA2 protein (p.Thr2370Ile). This variant is present in population databases (rs149561195, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with LAMA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 477501). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LAMA2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at